|
|||||
|
|
Predicting Injection Site Muscle Damage III: Evaluation of Intramuscular Formulations in the L6 Cell Model |
|
| Authors: | Evans Loreen A. F. Genereux Paul E. Gibbs E. Michael Sutton Steven C. |
| Affiliation: | (1) Pharmaceutical R & D Department, Central Research Division, Pfizer, Inc., Groton, Connecticut, 06340;(2) Metabolic Diseases Department, Central Research Division, Pfizer, Inc., Groton, Connecticut, 06340 |
| Abstract: | Pharmaceutical Research - |
| Keywords: | L6 cell monolayer intramuscular formulations creatine kinase |
| 本文献已被 SpringerLink 等数据库收录！ | |